You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MK-1775

Showing 1 - 25 of 884
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Boston, Houston

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 12, 2023

Lung Cancer Trial in Tampa, Columbus (Carboplatin, Paclitaxel, AZD1775)

Active, not recruiting
  • Lung Cancer
  • Tampa, Florida
  • +1 more
Feb 2, 2023

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Epithelial Ovarian Cancer Trial in Amsterdam (MK-1775 and carboplatin)

Active, not recruiting
  • Epithelial Ovarian Cancer
  • MK-1775 and carboplatin
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Dec 21, 2021

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States (Adavosertib)

Suspended
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Duarte, California
  • +8 more
Mar 15, 2022

Solid Tumors Trial run by the NCI (MK-1775 (AZD1775))

Completed
Has Results
  • Solid Tumors
  • MK-1775 (AZD1775)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2021

CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in

Active, not recruiting
Has Results
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Birmingham, Alabama
  • +23 more
Oct 7, 2022

Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Chicago, Illinois
  • +4 more
Jun 10, 2021

Advanced Malignant Solid Tumor Trial in United States (Adavosertib, Carboplatin, Everolimus)

Completed
Has Results
  • Advanced Malignant Solid Neoplasm
  • Aurora, Colorado
  • +7 more
Apr 11, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in Chapel Hill (AZD1775, Cisplatin, Intensity Modulated Radiotherapy Treatments)

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Jun 27, 2021

Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation Trial in Canada, Netherlands, United States (Adavosertib, Paclitaxel,

Active, not recruiting
Has Results
  • Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
  • Gilbert, Arizona
  • +19 more
Aug 23, 2022

Glioblastoma, GBM Trial in Phoenix (AZD1775)

Completed
  • Glioblastoma
  • GBM
  • AZD1775
  • Phoenix, Arizona
    Barrow Neurological Institute at St. Joseph's Hospital Medical C
Dec 9, 2020

Adenocarcinoma of the Pancreas Trial in Ann Arbor (MK-1775, Gemcitabine, Radiation Therapy)

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • MK-1775
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Hospital
Feb 13, 2020

Solid Tumors Trial (MK-1775, gemcitabine, cisplatin)

Completed
Has Results
  • Solid Tumors
  • MK-1775
  • +3 more
  • (no location specified)
Jan 9, 2019

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome With Isolated Del(5q), Myelodysplastic/Myeloproliferative Tumor Trial

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Aug 15, 2019

Head and Neck Squamous Cell Carcinoma Trial in Seattle (drug, other, procedure)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 11, 2019

Advanced Solid Tumours Trial in Australia, Japan, Korea, Republic of (AZD1775, Paclitaxel, carboplatin)

Completed
Has Results
  • Advanced Solid Tumours
  • Liverpool, Australia
  • +6 more
Mar 22, 2019

NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +4 more
  • MK-2870
  • +2 more
  • (no location specified)
Sep 15, 2023

Endometrial Cancer Trial (MK-2870, Doxorubicin, Paclitaxel)

Not yet recruiting
  • Endometrial Cancer
  • MK-2870
  • +2 more
  • (no location specified)
Nov 10, 2023

Schizophrenia Trial (MK-8189, Moxifloxacin, Placebo)

Not yet recruiting
  • Schizophrenia
  • (no location specified)
May 30, 2023

NSCLC, Renal Cell Carcinoma, Melanoma Trial (Pembrolizumab co-formulated with hyaluronidase, Pembrolizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Pembrolizumab co-formulated with hyaluronidase
  • Pembrolizumab
  • (no location specified)
Oct 19, 2023

Ulcerative Colitis Trial (IV MK-7240, IV Placebo, SC MK-7240)

Not yet recruiting
  • Ulcerative Colitis
  • IV MK-7240
  • +3 more
  • (no location specified)
Sep 27, 2023

Tumors Trial in Worldwide (MK-4830, Pembrolizumab, Carboplatin)

Recruiting
  • Neoplasms
  • San Francisco, California
  • +31 more
Dec 23, 2022

Schizophrenia Trial (MK-5720, Placebo)

Not yet recruiting
  • Schizophrenia
  • (no location specified)
Jul 24, 2023